Odyssey Health, Inc.

Odyssey Health, Inc. reported a net loss of $3.6 million for Q2 FY2026, a significant increase from a $0.22 million loss in the prior-year quarter, driven primarily by $2.6 million in financing costs and a $0.42 million loss from changes in derivative liabilities. The company generated no revenue, with operations resulting in a $0.18 million loss. Cash increased to $0.62 million from $0.02 million at the start of the period, supported by $1.2 million in net financing proceeds, while operating activities used $0.57 million. The balance sheet shows a working capital deficit of $10.6 million, with total assets of $0.72 million against current liabilities of $11.3 million, raising substantial doubt about the company's ability to continue as a going concern. Management indicates sufficient working capital to meet expenses through fiscal year-end 2026, contingent on securing additional funding.

Key Takeaways